AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Accuracy of the New Injury Severity Score in Evaluating Patients With Blunt Trauma

Recruitingn/aAges 18 Years - anyAllAl-Nahrain University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this prospective observational study is to evaluate the predictive utility of the New Injury Severity Score (NISS) in determining mortality outcomes among blunt trauma patients admitted to the Emergency Department of Kadhimiya Educational Hospital, Iraq. The main questions it aims to answer are: How accurately does NISS predict mortality in blunt trauma patients? What is the performance of NISS in predicting secondary outcomes, such as the need for intensive care and length of hospital stay? Participants will: Be assessed using the NISS score upon their admission to the emergency department. Have their clinical outcomes, including mortality, need for intensive care, and hospital stay, monitored throughout their hospitalization.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Trauma patients admitted to the emergency department, presenting with blunt trauma, such as from motor vehicle accidents, falls, or assaults. * Patients with adequate documentation of anatomical injuries and physiological parameters required for NISS calculation. * Injury assessment and NISS calculation completed within the first 6 hours of arrival to ensure accuracy and consistency in trauma evaluation. Exclusion Criteria: * Patients under 18 years, pregnant women, or those with pre-existing medical conditions that may alter trauma scoring accuracy or management outcomes. * Patients presenting with medical emergencies, terminal illnesses, or conditions unrelated to blunt trauma to ensure focus on trauma-specific evaluations. * Patients declared dead on arrival or who do not receive active treatment in the emergency department. * Patients or their families refusing participation or withdrawing consent at any stage of the study. * Patients transferred from or to another facility or those previously treated elsewhere, as this may affect data collection and scoring reliability.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
College of Medicine - Al-Nahrain University
Baghdad, Iraq
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy